MedTrace Logo

Clinical Assessment of a Closed-loop Insulin Delivery System

NCT01534013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2020-10-30

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to assess the safety and efficacy of the Imperial College closed loop insulin delivery system (artificial pancreas) in subjects with type 1 diabetes.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

DEVICE

The Imperial College Closed-Loop Insulin Delivery System

The Imperial College closed-loop insulin delivery system comprises 3 main components: the glucose sensor, the control algorithm and the insulin delivery system.

DEVICE

Open loop

glucose sensor and pump

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Desmond Johnston, MBChB,PhD,FRCP · Imperial College London

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2014-08-31
Completion
2018-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01534013 on ClinicalTrials.gov